Current Concepts in Pediatric Critical Care-20: Immune Dysfunction and Immunomodulation in the PICU

Video Transcription

Video Summary

Dr. Hines from St. Jude focused on immune dysregulation in pediatric critical care, emphasizing hyperinflammation and immunoparalysis. Highlighting the complexity of severe illnesses, she discussed the diverse phenotypes and endotypes that influence patient outcomes and the potential for targeted therapies. Dr. Hines described conditions like macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH), detailing their clinical features and biomarkers. She outlined therapeutic approaches, including using steroids, Anakinra, and emerging options like Ruxolitinib and Imipolimab for cytokine storms.<br /><br />She also delved into the challenges of immunoparalysis, which can complicate recovery in pediatric patients, particularly those with new infections or prolonged lymphopenia. Therapeutic interventions like GM-CSF are being explored. Dr. Hines stressed developing tailored strategies for specific patient groups, such as those in oncology or post-transplant, to optimize care and improve outcomes. The presentation underscored the path to personalizing pediatric critical care through understanding immune responses.

Keywords

immune dysregulation

pediatric critical care

hyperinflammation

immunoparalysis

targeted therapies

cytokine storms

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.